News
As the prospect of sector-specific tariffs under the second Trump administration continues to rattle drugmakers, a more ...
One of the FDA’s recently departed top officials is weighing in on the wide-ranging staff cuts at the agency and how they ...
The advisory committee, which met Tuesday for the first time since Robert F. Kennedy Jr. was sworn in as health secretary, ...
In the wake of unprecedented workforce cuts at the FDA, former Commissioner Scott Gottlieb and an unnamed former CBER ...
An advisory panel on vaccines meets, carefully, in the shadow of a health secretary who has often criticized it.
I called RFK Jr. an "extinction-level" threat to US biomedical science and public health. That extinction is under way.
After the gutting of the Department of Health and Human Services, fears mount about the future direction of the FDA—with ...
The former top vaccines official at the Food and Drug Administration criticized Health and Human Services Secretary Robert F.
Trump warned of coming pharma tariffs following an historic roller-coaster day for stocks in which the 90-day pause sparked a nearly 8% gain for the Dow Jones Industrial Average, which finished the ...
Peer-reviewed journals rejected their followup study on the 2023-2024 formulation of mRNA vaccines against the JN.1 variant ...
Dr. Peter Marks, an ex-FDA vaccine official, is warning of a fundamental change at the agency—where vaccine skepticism now ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results